Cargando…
Controversies in the treatment of postmenopausal osteoporosis: How long to treat with bisphosphonates?
Osteoporosis is a systemic skeletal disease characterized by reduced bone mass and deterioration of bone tissue microarchitecture leading to an increased risk of fractures. Fragility fractures, especially hip fractures, are associated with a significant reduction in the physical function and quality...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522084/ https://www.ncbi.nlm.nih.gov/pubmed/32725062 http://dx.doi.org/10.20945/2359-3997000000275 |